[go: up one dir, main page]

WO2007059491A8 - Nouveaux hydrogels et leurs utilisations - Google Patents

Nouveaux hydrogels et leurs utilisations

Info

Publication number
WO2007059491A8
WO2007059491A8 PCT/US2006/060882 US2006060882W WO2007059491A8 WO 2007059491 A8 WO2007059491 A8 WO 2007059491A8 US 2006060882 W US2006060882 W US 2006060882W WO 2007059491 A8 WO2007059491 A8 WO 2007059491A8
Authority
WO
WIPO (PCT)
Prior art keywords
novel hydrogels
hydrogels
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/060882
Other languages
English (en)
Other versions
WO2007059491A2 (fr
Inventor
Lisa Ann Butterick
Juliana Kretsinger
Bulent Ozbas
Karthikan Rajagopal
Darrin J Pochan
Joel P Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DELAWARE TECHNOLOGY Corp, University of
Original Assignee
DELAWARE TECHNOLOGY Corp, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DELAWARE TECHNOLOGY Corp, University of filed Critical DELAWARE TECHNOLOGY Corp, University of
Priority to CA002629897A priority Critical patent/CA2629897A1/fr
Priority to EP06839877A priority patent/EP1962870A4/fr
Priority to JP2008541458A priority patent/JP2009523118A/ja
Publication of WO2007059491A2 publication Critical patent/WO2007059491A2/fr
Publication of WO2007059491A8 publication Critical patent/WO2007059491A8/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
PCT/US2006/060882 2005-11-14 2006-11-14 Nouveaux hydrogels et leurs utilisations Ceased WO2007059491A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002629897A CA2629897A1 (fr) 2005-11-14 2006-11-14 Nouveaux hydrogels et leurs utilisations
EP06839877A EP1962870A4 (fr) 2005-11-14 2006-11-14 Nouveaux hydrogels et leurs utilisations
JP2008541458A JP2009523118A (ja) 2005-11-14 2006-11-14 新規ハイドロゲルおよびそれらの使用

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73584605P 2005-11-14 2005-11-14
US60/735,846 2005-11-14
US82715606P 2006-09-27 2006-09-27
US60/827,156 2006-09-27

Publications (2)

Publication Number Publication Date
WO2007059491A2 WO2007059491A2 (fr) 2007-05-24
WO2007059491A8 true WO2007059491A8 (fr) 2008-02-07

Family

ID=38049388

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/060882 Ceased WO2007059491A2 (fr) 2005-11-14 2006-11-14 Nouveaux hydrogels et leurs utilisations

Country Status (5)

Country Link
US (2) US7858585B2 (fr)
EP (1) EP1962870A4 (fr)
JP (1) JP2009523118A (fr)
CA (1) CA2629897A1 (fr)
WO (1) WO2007059491A2 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7884185B2 (en) * 2004-07-28 2011-02-08 University Of Delaware Hydrogels and uses thereof
US20090232784A1 (en) * 2005-03-10 2009-09-17 Dale Feldman Endothelial predecessor cell seeded wound healing scaffold
US8062890B2 (en) 2005-08-15 2011-11-22 Wisconsin Alumni Research Foundation Defined surfaces of self-assembled monolayers and stem cells
WO2007059491A2 (fr) * 2005-11-14 2007-05-24 University Of Delaware Technology Corporation Nouveaux hydrogels et leurs utilisations
US20090183503A1 (en) * 2008-01-18 2009-07-23 Alberto Verdesi Exhaust apparatus
WO2009117497A1 (fr) * 2008-03-19 2009-09-24 University Of Delaware Délivrance d'hydrogels sous la forme de pulvérisations
WO2009149328A2 (fr) * 2008-06-05 2009-12-10 The Administrators Of The Tulane Educational Fund Procédés et instrumentation pour surveiller pendant la synthèse l’évolution fonctionnelle d’un polymère
US8834926B2 (en) * 2008-08-08 2014-09-16 University Of Delaware Macromolecular diffusion and release from self-assembled β-hairpin peptide hydrogels
US8648170B2 (en) * 2008-09-19 2014-02-11 Wisconsin Alumni Research Foundation Peptide-presenting surfaces for long-term culture of pluripotent cells
RU2011118341A (ru) 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) Агент для окклюзии тканей
WO2010151353A2 (fr) * 2009-03-24 2010-12-29 University Of Delaware Hydrogel injectable à base de peptide à structure bêta-hairpin détruisant staphylococcus aureus résistant à la méthicilline
US8062555B2 (en) * 2009-04-16 2011-11-22 Rhodia Operations Co-assembly method and co-assembled structures made thereby
US20110081398A1 (en) * 2009-10-01 2011-04-07 Tyco Healthcare Group Lp Multi-mechanism surgical compositions
CA2787007A1 (fr) * 2010-01-12 2011-07-21 Purdue Research Foundation Materiaux et methodes de production de membranes bio-inorganiques non naturelles dirigees par surface cellulaire et associees et leurs applications
US8741833B2 (en) 2010-07-16 2014-06-03 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
WO2012008967A1 (fr) * 2010-07-16 2012-01-19 Massachusetts Institute Of Technology Peptides autoassemblés comprenant des modifications et leurs procédés d'utilisation
US8546338B2 (en) 2010-12-08 2013-10-01 Johnson & Johnson Consumer Companies, Inc. Self-assembling hydrogels based on dicephalic peptide amphiphiles
GB201203085D0 (en) 2012-02-22 2012-04-04 Univ Manchester Hydrogels
US9132171B2 (en) 2012-05-23 2015-09-15 Wisconsin Alumni Research Foundation Test of insulin as a drug to reduce restenosis of vessels
CN104902974B (zh) 2012-07-06 2017-07-28 三维矩阵有限公司 肽溶液的灌装加工法
US9827321B2 (en) 2012-08-14 2017-11-28 The Trustees Of The University Of Pennsylvania Stabilizing shear-thinning hydrogels
SG11201500111VA (en) * 2012-08-29 2015-03-30 Agency Science Tech & Res Peptides and uses thereof
JP6628733B2 (ja) 2014-03-10 2020-01-15 株式会社スリー・ディー・マトリックス 自己組織化ペプチド組成物
WO2015136370A2 (fr) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Stérilisation et de filtration de compositions de peptides
US10086108B2 (en) 2015-01-22 2018-10-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hydrogels and use thereof in anastomosis procedures
WO2017053765A1 (fr) * 2015-09-25 2017-03-30 University Of Delaware Utilisation d'échafaudages en hydrogels peptidiques pour la découverte tridimensionnelle à haut débit de médicaments
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
JP6711424B2 (ja) 2017-02-01 2020-06-17 株式会社島津製作所 細胞培養用ゲル組成物およびその製造方法、細胞培養方法ならびに細胞培養用基板
US11661439B2 (en) 2017-12-17 2023-05-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Peptide hydrogels and use thereof
US11904057B2 (en) * 2018-02-10 2024-02-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Nanoparticle-hydrogel composite for nucleic acid molecule delivery
KR20220106993A (ko) * 2019-11-26 2022-08-01 나익셔 테크놀로지스 에이비 일반적인 고용량 단백질을 포획하고, 조정하는 전기화학적 방출
WO2022035779A1 (fr) * 2020-08-10 2022-02-17 Gel4Med, Inc. Hydrogels de peptides amphiphiles pouvant s'auto-assembler
EP4384532A4 (fr) * 2021-08-09 2025-07-02 Gel4Med Inc Hydrogels peptidiques amphiphiles à auto-assemblage pour le traitement d'une lésion nerveuse
CN114377202B (zh) * 2021-12-16 2023-01-24 方向前 适用于软骨再生的功能化自组装miRNA/多肽复合水凝胶及其制备方法
EP4601730A1 (fr) * 2022-10-14 2025-08-20 The Governing Council of the University of Toronto Compositions pour systèmes d'administration de médicament sensibles au glucose par l'intermédiaire de micro-aiguilles multifonctionnelles à base d'hydrogel
WO2025151125A1 (fr) * 2024-01-12 2025-07-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Composite nanoparticules-hydrogel pour l'administration de molécules d'acides nucléiques

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435047A (en) * 1981-09-16 1984-03-06 Manchester R & D Partnership Encapsulated liquid crystal and method
EP0363504A1 (fr) 1988-10-10 1990-04-18 Dräger Nederland B.V. Procédé pour réaliser une couche comprenant un hydrogel à base de polyvinyle et une substance à activité biochimique sur un substrat
DE9390311U1 (de) 1993-05-18 1996-05-09 I.D.M. Immuno-Designed Molecules, Paris Neue Makrophagen mit Eignung als Wirkstoffe von pharmazeutischen Zusammensetzungen
DE69430243T2 (de) * 1993-12-01 2002-10-17 Bioartificial Gel Technologies Inc., Montreal Hydrogel auf basis von albumin
WO1996029987A1 (fr) * 1995-03-24 1996-10-03 Focal, Inc. Diminution des adherences par liberation controlee d'inhibiteurs d'oxygene actif
US5965532A (en) 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US5807757A (en) 1996-07-02 1998-09-15 Virus Research Institute, Inc. Preparation of ionically cross-linked polyphosphazene microspheresy by coacervation
US20010038855A1 (en) * 1998-06-05 2001-11-08 Desjardin Michael A. Dosage form for administering prescribed dose
US6514689B2 (en) * 1999-05-11 2003-02-04 M-Biotech, Inc. Hydrogel biosensor
US9314339B2 (en) * 2000-03-27 2016-04-19 Formae, Inc. Implants for replacing cartilage, with negatively-charged hydrogel surfaces and flexible matrix reinforcement
US7884185B2 (en) * 2004-07-28 2011-02-08 University Of Delaware Hydrogels and uses thereof
WO2007059491A2 (fr) * 2005-11-14 2007-05-24 University Of Delaware Technology Corporation Nouveaux hydrogels et leurs utilisations

Also Published As

Publication number Publication date
WO2007059491A2 (fr) 2007-05-24
US7858585B2 (en) 2010-12-28
US20070128175A1 (en) 2007-06-07
JP2009523118A (ja) 2009-06-18
EP1962870A2 (fr) 2008-09-03
EP1962870A4 (fr) 2010-08-11
US20110052692A1 (en) 2011-03-03
CA2629897A1 (fr) 2007-05-24

Similar Documents

Publication Publication Date Title
WO2007059491A8 (fr) Nouveaux hydrogels et leurs utilisations
EP1781336A4 (fr) Nouveaux hydrogels et leurs utilisations
AU2006339063A8 (en) Macro-diacrylates and macro-polyacrylates
AU2005100155A4 (en) Boardsling
AU2005902195A0 (en) Composition and uses thereof
AU2005903905A0 (en) Novel rhizobacteria and uses thereof
AU2005101012A4 (en) Phoneblock
AU2005100875A4 (en) Venti - geni
AU2005100156A4 (en) Auscar
AU2005100452A4 (en) Sqeg
AU2005100098A4 (en) Vent - A - Loo
AU2005100082A4 (en) Mobilus
AU2005100778A4 (en) Halta
AU2005100821A4 (en) MediDirect
AU2005100866A4 (en) Infopower
AU2005905904A0 (en) Leukocyte-binding polypeptides and uses thereof
HK1116833A (en) Replikin peptides and uses thereof
AU2005903025A0 (en) Novel Coil and Uses Thereof
HK1111163A (en) Dihydroxyanthraquinones and their use
HK1118480A (en) Novel process and formulations
HK1105782A (en) Substituted amino-pyrimidones and uses thereof
HK1110201A (en) Phycotoxins and uses thereof
AU2005901521A0 (en) Condition Matching
AU2005900017A0 (en) Medichair
AU2005900027A0 (en) Biotek - Pain Relief - Bandage

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2629897

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2008541458

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006839877

Country of ref document: EP